Cargando…

Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation?

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Patmore, H S, Ashman James, N E, Cawkwell, L, MacDonald, A, Stafford, N D, Greenman, J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409886/ http://dx.doi.org/10.1038/sj.bjc.6602114

Ejemplares similares

Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation?
por: Patmore, H S, et al.
Publicado: (2004)

Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation
por: Ashman, J N E, et al.
Publicado: (2003)

Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation
por: Berrieman, H K, et al.
Publicado: (2004)

Bcl-2 expression predicts radiotherapy failure in laryngeal cancer
por: Nix, P, et al.
Publicado: (2005)

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma
por: Jamieson, Stephen M.F., et al.
Publicado: (2023)

The synthesis and application of nano doxorubicin-indocyanine green matrix metalloproteinase-responsive hydrogel in chemophototherapy for head and neck squamous cell carcinoma [Corrigendum]
Publicado: (2019)

Corrigendum to “Long Noncoding RNA LINC00460 Promotes Cell Progression by Sponging miR-4443 in Head and Neck Squamous Cell Carcinoma”
Publicado: (2021)

Corrigendum to “SEC11A contributes to tumour progression of head and neck squamous cell carcinoma” [Heliyon 9(4) (April 2023) e14958]()
por: Shen, Hailong, et al.
Publicado: (2023)

Corrigendum to ‘A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)’
por: Low, Joo-Leng, et al.
Publicado: (2021)

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
por: Balermpas, P, et al.
Publicado: (2014)

Corrigendum to “Epidemiological Trends of Head and Neck Cancer: A Population-Based Study”
por: Guo, Kangwen, et al.
Publicado: (2021)

Validation of the Chinese Version of the Shame and Stigma Scale in Patients with Head and Neck Cancer [Corrigendum]
Publicado: (2020)

Corrigendum for The clinicopathological and microRNA expression signature associated with lymphovascular invasion in squamous cell carcinoma: a basic descriptive study
Publicado: (2022)

Malignant and Nonmalignant Gene Signatures in Squamous Head and Neck Cancer
por: Worsham, Maria J., et al.
Publicado: (2012)

Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma
por: Li, Cheng, et al.
Publicado: (2020)

Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
por: Redman, Jason M., et al.
Publicado: (2023)

Osteopontin Levels in Patients with Squamous Metastatic Head and Neck Cancer
por: Maleš, Josip, et al.
Publicado: (2021)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer
por: Lajer, C B, et al.
Publicado: (2017)

Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021)

The prognostic impact of the immune signature in head and neck squamous cell carcinoma
por: Baysal, Hasan, et al.
Publicado: (2022)

Maintenance of head and neck tumor on-chip: gateway to personalized treatment?
por: Bower, Ruth, et al.
Publicado: (2017)

Characterisation of anaemia amongst school going adolescent girls in rural Haryana, India – CORRIGENDUM
por: Gupta, Aakriti, et al.
Publicado: (2023)

Corrigendum to ‘Characterisation of a mobilisable plasmid conferring florfenicol and chloramphenicol resistance in Actinobacillus pleuropneumoniae’ [Veterinary Microbiology 178 (2015) 279–282]
por: Bossé, Janine T., et al.
Publicado: (2015)

Cathepsins B, D, and G Are Expressed in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma
por: Humphries, Felix, et al.
Publicado: (2021)

Microbial Communities Associated with Primary and Metastatic Head and Neck Squamous Cell Carcinoma – A High Fusobacterial and Low Streptococcal Signature
por: Shin, Jae M., et al.
Publicado: (2017)

Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity
por: Tittarelli, A, et al.
Publicado: (2016)

Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma
por: Arron, Sarah T., et al.
Publicado: (2022)

Clinical correlation of opposing molecular signatures in head and neck squamous cell carcinoma
por: Qadir, Fatima, et al.
Publicado: (2019)

Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures
por: Mes, Steven W., et al.
Publicado: (2020)

Development and Validation of an Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma
por: Liu, Chang, et al.
Publicado: (2021)

Mast cell marker gene signature in head and neck squamous cell carcinoma
por: Cai, Zhimou, et al.
Publicado: (2022)

Proteome and phosphoproteome signatures of recurrence for HPV(+) head and neck squamous cell carcinoma
por: Kaneko, Tomonori, et al.
Publicado: (2022)

Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma
por: Lin, Cheng, et al.
Publicado: (2023)

A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer
por: Khan, O A, et al.
Publicado: (2009)

Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands
por: van der Linden, Naomi, et al.
Publicado: (2015)

Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
por: Chen, Wen-Chun, et al.
Publicado: (2017)

Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Borel, Christian, et al.
Publicado: (2020)

A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
por: Couteau, C, et al.
Publicado: (1999)

Hookah smoking, nass chewing, and oesophageal squamous cell carcinoma in Kashmir, India
por: Dar, N A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7l90le7v54ngkc04p3m7e8gf6b